Ryan Hicks

Senior Director – Head of Bioscience Cell Therapy, BioPharmaceuticals, R&D Cell Therpay • AstraZeneca

Ryan Hicks is a Senior Director and Head of Bioscience Cell Therapy, within the Cell Therapy Department of BioPharmaceuticals R&D at AstraZeneca. Ryan is responsible for leading the section driving the discovery and development of cell therapy-based projects, primarily in the pre-clinical phase, across cardiovascular, renal, metabolic, respiratory and immunological disease areas.

Ryan is an expert cell and molecular scientist with over 20 years of drug discovery and development experience. Ryan is an accomplished line and project leader, having worked across multiple disease areas, geographies and therapeutic modalities including Therapeutic Genome Editing Cell Therapy.

Ryan has led multiple external collaborations with industrial and academic partners, and supervised several Postdoc and Ph.D scientists. Ryan has over 25 peer reviewed publications, received his degree in Medical Biochemistry from the University of Birmingham, UK in 1997 and his Ph.D. in Biochemistry and Molecular Biology from the University of Leeds, UK, in 2001

Also speaking

Uta Griesenbach

Professor of Molecular Medicine, National Heart and Lung Institute • Imperial College London

Owen Smith

Partner • 4Bio

Silvio Weber

Director Industrial Workflow Development, Cellular Therapy • Miltenyi Biotec

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.